Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE: Pharmacogenetic-guided Warfarin Dosing
NCT00377143Phase 4Withdrawn
- Sponsor
- University of Florida
- Start
- Jul 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in venous thromboembolism (VTE) and pulmonary embolism (PE) (2 arms), sponsored by University of Florida. Primary endpoint: Accuracy of the initial versus the stable warfarin dose. Planned start Jul 2006; status: withdrawn.
02
Drugs
warfarin
03
Conditions
venous thromboembolism (VTE)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00377143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377143.